IBMS/ECTS 2001 - PROGRAM and ABSTRACTS

PLENARY SESSION 4

OSTEOPOROSIS: EVALUATION AND TREATMENT

Chairs: John A. Kanis (Sheffield /UK),
Jan Stepan (Prague/Czech Republic)

Friday, June 8, 2001
08:30 - 09:30 Auditorium

IN8

Diagnostic Evaluation of Osteoporosis

Richard Eastell (Sheffield/UK)

IN9

All the Kings Horses and All the Kings Men Could Never Put Humpty Dumpty Back Together Again

Ego Seeman (Heidelberg, Melbourne/Australia)

[Friday at a Glance]  [Contents page]

ORAL PRESENTATIONS 4

OSTEOPOROSIS: EVALUATION AND TREATMENT

Chairs: John A. Kanis (Sheffield /UK),
Jan Stepan (Prague/Czech Republic)

Friday, June 8, 2001
09:30 - 11:10 Auditorium

The abstract text of oral presentations (prefix OR) can be found in the Abstracts section. Click on the Abstract number.

09:30 OR27

HORMONAL REPLACEMENT THERAPY REDUCES FOREARM FRACTURE INCIDENCE IN RECENT POSTMENOPAUSAL WOMEN - RESULTS OF THE DANISH OSTEOPOROSIS PREVENTION STUDY

L. Mosekilde*, H. Beck-Nielsen, O. H. Sørensen, S. P. Nielsen, P. Charles, P. Vestergaard

Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus, Denmark; Department of Endocrinology M, Odense University Hospital, Odense, Denmark; Department of Medicine, Hvidovre Hospital, Hvidovre, Denmark; Department of Clinical Physiology, Hillerød Hospital, Hillerød, Denmark

09:42 OR28

SIDE EFFECT SEVERITY AND DISCONTINUATION RATE AMONG WOMEN INITIATING HORMONE REPLACEMENT THERAPY, RALOXIFENE, OR ALENDRONATE FOLLOWING BMD TESTING

B. Ettinger*, A. N. A. Tosteson, M. Grove, M. Moncur, A. R. Pressman, G. T. Ray, G. M. Hebert, C. Hammond

Division of Research, Kaiser Permanente Medical Care Program, Oakland, USA; Clinical Research Section, Darmouth-Hitchcock Medical Center, Lebanon, USA

09:54 OR29

TREATMENT WITH RECOMBINANT HUMAN PARATHYROID HORMONE (1-34) DECREASES THE SEVERITY AND SEQUELAE OF VERTEBRAL FRACTURES

G. Goemaere*, J-M. Kaufman, O. Wang, B. H. Mitlak

Ghent University Hospital, Ghent, Belgium; Eli Lilly and Company, Indianapolis, IN, USA

10:06 OR30

TWO YEARS OF PARATHYROID HORMONE 1-34 AND ESTROGEN PRODUCE DRAMATIC BONE DENSITY INCREASES IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN THAT DISSIPATE ONLY SLIGHTLY DURING A THIRD YEAR OF TREATMENT WITH ESTROGEN ALONE:- RESULTS FROM A PLACEBO-CONTROLLED RANDOMIZED TRIAL

C. D. Arnaud*, E. B. Roe, M. S. Sanchez, P. Bacchetti, D. M. Black, C. E. Cann

University of California, San Francisco, USA; University of Manitoba, USA

11:18 OR31

EFFECTS OF THE SELECTIVE ESTROGEN RECEPTOR MODULATOR RALOXIFENE ON BONE METABOLISM AND PITUITARY-GONADAL AXIS IN HEALTHY MIDDLE-AGED MEN

B. Uebelhart*, J. P. Bonjour, M. Draper, I. Pavo, R. Rizzoli

Division of Bone Diseases, University Hospital, Geneva, Switzerland; Eli Lilly and Company, Indianapolis, Indiana, USA; Lilly Area Medical Center, Vienna, Austria

11:30 OR32

THE LEVEL OF ENDOGENOUS ESTRADIOL DETERMINES THE THERAPEUTIC RESPONSE TO A SELECTIVE ESTROGEN RECEPTOR MODULATOR IN ELDERLY MEN

P. M. Doran*, B. L. Riggs, E. J. Atkinson, W. M. O'Fallon, L. J. Melton, Iii, S. Khosla

Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA

11:42 OR33

CAN THREE DROPS OF VITAMIN D PREVENT HIP FRACTURES?

M. Billsten*, I. Rodine, E. Ornstein, O. Johnell, I. Sernbo

1Departments of Orthopaedics Hassleholm-Kristianstad hospital, S-29185 Kristianstad, Sweden; 2Department of Orthopaedics, Malmo University Hospital, S-205 02 Malmo, Sweden

11:54 OR34

PAMIDRONATE TREATMENT IMPROVES GROSS MOTOR FUNCTION AND GROWTH IN CHILDREN WITH OSTEOGENESIS IMPERFECTA

H. Plotkin*, J. Gibis, F. H. Glorieux

Genetics Unit, Shriners Hospital for Children, and the Departments of Surgery and Pediatrics, McGill University, Montréal, Québec, Canada

[Friday at a Glance]  [Contents page]